Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;159(5):2115-2116.
doi: 10.1016/j.chest.2020.11.069.

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019

Martin Mombrun  1 , Xavier Valette  2
Affiliations
Comment

Questioning Tocilizumab Use in Hospitalized Patients With Coronavirus Disease 2019

Martin Mombrun et al. Chest. 2021 May.
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Price CC, Altice FL, Azar MM, McManus D, Gleeson SE, Britto CJ, Azmy V, Kaman K, Davis M, Chupp G, Bucala R, Kaminski N, Topal JE, Dela Cruz C, Malinis M. Price CC, et al. Chest. 2021 May;159(5):2116-2117. doi: 10.1016/j.chest.2020.12.032. Chest. 2021. PMID: 33965143 Free PMC article. No abstract available.

Comment on

Similar articles

See all similar articles

References

    1. Price C.C., Altice F.L., Shyr Y. Tocilizumab treatment for cytokine release syndrome in hospitalized patients with coronavirus disease 2019: survival and clinical outcomes. Chest. 2020;158(4):1397–1408. - PMC - PubMed
    1. Lee D.W., Gardner R., Porter D.L. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188–195. - PMC - PubMed
    1. Hermine O., Mariette X., Tharaux P.-L. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med. 2021;181(1):32–40. - PMC - PubMed
    1. Lamontagne F., Agoritsas T., Macdonald H. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. - PubMed
    1. Stone J.H., Frigault M.J., Serling-Boyd N.J. Efficacy of tocilizumab in patients hospitalized with Covid-19. N Engl J Med. 2020;383(24):2333–2344. - PMC - PubMed

Substances